Glasgow Memory Clinic is about to begin a year long trial to test the effectiveness of experimental drug Dimebon. It is hoped that this new drug will help by improving memory, cognition and the ability for care for oneself.
The trial, which has now begun enrolling more than 1,000 selected patients from around the world, is open to patients currently taking Aricept which is the most common and leading medication currently available for the disease.
Founder of the Glasgow Memory Clinic, Dr Fraser Inglis has said that he feels optimistic about the trial and hopes it could make advances in the treatment of the disease.
Although there are currently medications that can improve the symptoms for some patients for a time, it’s likely that the disease will still progress even if the process is slowed down. Therefore, combination therapy could be the answer to maximising clinical benefit.
Dr Inglis added: “A cure for Alzheimer’s is still many years away, however treatments that provide lasting effects, more symptomatic benefits or slow disease progression would offer meaningful benefits for patients and their carers.”